Monopar Therapeutics MNPR Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$3.89M-48.3% | -$5.2M+52.4% | -$3.44M-164% | -$2.45M-43.0% | -$2.62M-59.9% | ||
| $1.69M+24.9% | $1.1M+296% | $1.1M+452% | $1.28M+283% | $1.36M+312% | ||
| -$287.14K+62.8% | $738.68K-34.9% | —— | —— | -$770.97K-148% | ||
| $187.04K-62.7% | -$709.4K-2,484% | $107.24K+3,721% | $84.72K+270% | $502.03K+1,300% | ||
| -$3.47M+38.7% | -$3.37M-68.6% | -$2.09M-94.7% | -$1.08M+35.7% | -$5.66M-242% | ||
| $40.84M+2,021% | $78.29M+446% | $5.73M— | $1.21M+49,950% | $1.93M+95.9% | ||
| $35.25M+2,103% | $16.1M— | $3.6M+265% | $2.4M— | $1.6M— | ||
| -$5.58M-1,614% | -$62.19M-334% | -$2.13M-316% | $1.19M+49,101% | -$325.83K+66.9% | ||
| $0— | $0-100% | $0— | $0— | $0-100% | ||
| $200.2K+52.7% | $298.09K+345% | $381.56K+2,208% | $321.56K+3,115% | $131.13K+1,121% | ||
| -$200.2K-73.1% | $0-100% | $92.39M— | -$316.85K— | -$115.68K-104% | ||
| -$31.63K-58,470% | $99.5K— | $376-91.6% | -$2.55K— | -$54+96.7% | ||
| -$9.29M-52.2% | —— | $88.18M+88,411% | -$209.47K+87.6% | -$6.1M-1,227% | ||
| $799.63K+569% | —— | —— | —— | $119.51K+5,202% | ||
| $187.04K-62.7% | -$709.4K-2,484% | $107.24K+3,721% | $84.72K+270% | $502.03K+1,300% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $40.84M+2,021% | $78.29M+446% | $5.73M— | $1.21M+49,950% | $1.93M+95.9% | ||
| $35.25M+2,103% | $16.1M— | $3.6M+265% | $2.4M— | $1.6M— | ||
| -$31.63K-58,470% | $99.5K— | $376-91.6% | -$2.55K— | -$54+96.7% | ||
| -$0-100% | —— | —— | —— | $3M— | ||
| $25-97.1% | $5K— | $0— | $3.58K— | $850+120% | ||
| $291.73K+2,846% | $164.09K— | $0— | $117.44K— | $9.9K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Monopar Therapeutics generate?
- Monopar Therapeutics (MNPR) generated -$10.0M in operating cash flow over the trailing twelve months.
- Where does Monopar Therapeutics's cash flow data come from?
- Every line is extracted from Monopar Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.